GRIFOLS | GRF - Себестоимость





Себестоимость Изменить Дата
Alcon AG USD 1.2B 46M 2025-12
Almirall EUR 191.5M 2.29M 2025-12
Amadeus IT EUR 641.1M 260.4M 2025-12
Amarin USD 26.05M 1.41M 2025-12
argenx SE USD 149.69M 40.26M 2025-12
AstraZeneca USD -204M 3.48B 2026-03
Bayer EUR 4.5B 194M 2025-12
Cie Automotive EUR 1.21B 19.7M 2025-12
Demant DKK 2.89B 188M 2025-12
Ence Energia y Celulosa EUR 109.33M 21.97M 2025-12
Essilor EUR 6.06B 741M 2025-12
Ferrovial EUR 867M 120M 2025-12
Fresenius EUR 4.45B 262M 2025-12
Fresenius Medical Care EUR 3.68B 38.37M 2025-12
Galapagos EUR 455K 84.28M 2025-12
Genmab DKK 81M 23M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
GRIFOLS EUR 1.29B 163.12M 2025-12
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Inditex EUR 6.19B 1.67B 2025-12
Merck EUR 2.29B 183M 2025-12
Novartis USD 3.54B 3M 2025-12
Philips EUR 2.81B 417M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.67B 621M 2026-03
Smith & Nephew USD 870M 17M 2025-12
UCB EUR 1.07B 146M 2025-12
Viscofan EUR 192.48M 10.12M 2026-03